These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 16840400

  • 1. Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension.
    Sanchez O, Sitbon O, Jaïs X, Simonneau G, Humbert M.
    Chest; 2006 Jul; 130(1):182-9. PubMed ID: 16840400
    [Abstract] [Full Text] [Related]

  • 2. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases.
    Jais X, Launay D, Yaici A, Le Pavec J, Tchérakian C, Sitbon O, Simonneau G, Humbert M.
    Arthritis Rheum; 2008 Feb; 58(2):521-31. PubMed ID: 18240255
    [Abstract] [Full Text] [Related]

  • 3. Predictors of Favorable Responses to Immunosuppressive Treatment in Pulmonary Arterial Hypertension Associated With Connective Tissue Disease.
    Yasuoka H, Shirai Y, Tamura Y, Takeuchi T, Kuwana M.
    Circ J; 2018 Jan 25; 82(2):546-554. PubMed ID: 28904255
    [Abstract] [Full Text] [Related]

  • 4. Treatment of Vasodilator-resistant Mixed Connective Tissue Disease-associated Pulmonary Arterial Hypertension with Glucocorticoid and Cyclophosphamide.
    Sugawara E, Kato M, Hisada R, Oku K, Bohgaki T, Horita T, Yasuda S, Atsumi T.
    Intern Med; 2017 Jan 25; 56(4):445-448. PubMed ID: 28202869
    [Abstract] [Full Text] [Related]

  • 5. Bosentan therapy of pulmonary arterial hypertension in connective tissue diseases.
    Cozzi F, Montisci R, Marotta H, Bobbo F, Durigon N, Ruscazio M, Sfriso P, Iliceto S, Todesco S.
    Eur J Clin Invest; 2006 Sep 25; 36 Suppl 3():49-53. PubMed ID: 16919011
    [Abstract] [Full Text] [Related]

  • 6. The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review.
    Kato M, Kataoka H, Odani T, Fujieda Y, Otomo K, Oku K, Horita T, Yasuda S, Atsumi T, Ohira H, Tsujino I, Nishimura M, Koike T.
    Lupus; 2011 Oct 25; 20(10):1047-56. PubMed ID: 21676917
    [Abstract] [Full Text] [Related]

  • 7. Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study.
    Kommireddy S, Bhyravavajhala S, Kurimeti K, Chennareddy S, Kanchinadham S, Rajendra Vara Prasad I, Rajasekhar L.
    Rheumatology (Oxford); 2015 Sep 25; 54(9):1673-9. PubMed ID: 25929760
    [Abstract] [Full Text] [Related]

  • 8. [Pulmonary arterial hypertension related to connective tissue diseases].
    Pehlivan O, Inanç M.
    Anadolu Kardiyol Derg; 2010 Aug 25; 10 Suppl 1():57-62. PubMed ID: 20819768
    [Abstract] [Full Text] [Related]

  • 9. Diastolic function of the heart in mixed connective tissue disease.
    Végh J, Hegedus I, Szegedi G, Zeher M, Bodolay E.
    Clin Rheumatol; 2007 Feb 25; 26(2):176-81. PubMed ID: 16865311
    [Abstract] [Full Text] [Related]

  • 10. [Pulmonary arterial hypertension associated with connective tissue diseases].
    Legendre P, Mouthon L.
    Presse Med; 2014 Sep 25; 43(9):957-69. PubMed ID: 25129118
    [Abstract] [Full Text] [Related]

  • 11. Comparison of baseline characteristics and survival between patients with idiopathic and connective tissue disease-related pulmonary arterial hypertension.
    Ruiz-Cano MJ, Escribano P, Alonso R, Delgado J, Carreira P, Velazquez T, Sanchez MA, Sáenz de la Calzada C.
    J Heart Lung Transplant; 2009 Jun 25; 28(6):621-7. PubMed ID: 19481024
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.
    Launay D, Sitbon O, Le Pavec J, Savale L, Tchérakian C, Yaïci A, Achouh L, Parent F, Jais X, Simonneau G, Humbert M.
    Rheumatology (Oxford); 2010 Mar 25; 49(3):490-500. PubMed ID: 20015974
    [Abstract] [Full Text] [Related]

  • 13. [The clinical analysis of pulmonary arterial hypertension in connective tissue disease].
    Ji YQ, Zhang ZL, Lu WX.
    Zhonghua Nei Ke Za Zhi; 2006 Jun 25; 45(6):467-71. PubMed ID: 16831323
    [Abstract] [Full Text] [Related]

  • 14. Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.
    Oudiz RJ, Schilz RJ, Barst RJ, Galié N, Rich S, Rubin LJ, Simonneau G, Treprostinil Study Group.
    Chest; 2004 Aug 25; 126(2):420-7. PubMed ID: 15302727
    [Abstract] [Full Text] [Related]

  • 15. [Pulmonary arterial hypertension in connective tissue diseases].
    Cordier JF.
    Bull Acad Natl Med; 2009 Nov 25; 193(8):1911-8; discussion 1918-9. PubMed ID: 20669554
    [Abstract] [Full Text] [Related]

  • 16. [Pulmonary arterial hypertension in connective tissue disease].
    Cottin V.
    Rev Mal Respir; 2006 Sep 25; 23(4 Suppl):13S61-72. PubMed ID: 17057632
    [Abstract] [Full Text] [Related]

  • 17. Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment.
    Tanaka E, Harigai M, Tanaka M, Kawaguchi Y, Hara M, Kamatani N.
    J Rheumatol; 2002 Feb 25; 29(2):282-7. PubMed ID: 11838845
    [Abstract] [Full Text] [Related]

  • 18. Immunosuppressive therapy in patients with connective tissue disease-associated pulmonary arterial hypertension: A systematic review.
    Ding Y, Qian J, Zhang S, Xu D, Leng X, Zhao J, Wang Q, Zhang W, Tian X, Li M, Zeng X.
    Int J Rheum Dis; 2022 Sep 25; 25(9):982-990. PubMed ID: 35699128
    [Abstract] [Full Text] [Related]

  • 19. Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis.
    Distler O, Ofner C, Huscher D, Jordan S, Ulrich S, Stähler G, Grünig E, Held M, Ghofrani HA, Claussen M, Lange TJ, Klose H, Rosenkranz S, Vonk-Noordegraaf A, Vizza CD, Delcroix M, Opitz C, Pausch C, Scelsi L, Neurohr C, Olsson KM, Coghlan JG, Halank M, Skowasch D, Behr J, Milger K, Remppis BA, Skride A, Jureviciene E, Gumbiene L, Miliauskas S, Löffler-Ragg J, Wilkens H, Pittrow D, Hoeper MM, Ewert R.
    Rheumatology (Oxford); 2024 Apr 02; 63(4):1139-1146. PubMed ID: 37462520
    [Abstract] [Full Text] [Related]

  • 20. Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.
    Denton CP, Humbert M, Rubin L, Black CM.
    Ann Rheum Dis; 2006 Oct 02; 65(10):1336-40. PubMed ID: 16793845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.